OP0014 Serum urate, gout, and cardiovascular disease in a randomised controlled trial of canakinumab: a cantos secondary analysis
Year: 2018
Type: conference-abstract
Source: Annals of the Rheumatic Diseases
Institutions: Harvard University, Novartis (Switzerland)
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Pfizer, Chugai Pharmaceutical
OpenAlex ID: W2808741561
